Al's Comment:

 These 2 projects are exciting. The first is looking to see if a new drug crosses the blood brain barrier and works in tumor models. If it does, they will follow up with a human trial.  The second helps fund the Children's Brain Tumor Network.  We are a foundational partner of the CBTN now.  This collaboration will speed up the pace of research, making it possible to do things we never imagined! I think this will speed up the search for the cure. 

 

 


Posted on: 02/04/2021

Musella Foundation awards two brain tumor research grants!

  
Hewlett, NY 2/4/2021 - The Musella Foundation is pleased to announce that we have awarded two more  brain tumor research grants in the total amount of $55,000.  
 
The projects:
 
  1. $30,000 grant to Dr. Andrew Grove, of Dana-Farber Cancer Institute for the "Characterization of a Novel Largazole-Based HDAC Inhibitor as a Potential CNS Penetrant Drug for the Treatment of H3K27M Diffuse Midline Glioma (DMG)". This is from our DIPG All-In-Initiative.
  2. $25,000 grant to the CHOP Foundation for the "Children's Brain Tumor Network". The CBTN runs the largest biorepository for pediatric brain tumor samples, which includes the complete genetic profiling of patients, and the creation of brain tumor models, which they share with other researchers. This is accelerating the pace of research.

    About the Musella Foundation 
The Musella Foundation For Brain Tumor Research & Information, Inc is a 501(c)3 non- profit organization dedicated to speeding up the search for the cure of brain tumors, as well as helping families deal with the diagnosis of brain cancer, by funding innovative brain tumor research, education, advocacy, emotional and financial support for families that are dealing with brain tumors and organizing the brain tumor community to work together as an army to fight the disease. Our patient navigation program is unlike any other such program – a team of experts evaluate each case, and we track the outcomes so we learn from every patient.
 
 
 
 

 


Click HERE to return to brain tumor news headlines.